|
香杉芝抗氧化及抗癌功效之探討 . 朝陽科技大學應用化學系碩士論 文. 台中, 台灣, 2007. 2. Shen, C.C., et al., Bioactive components from the mycelium of Antrodia salmonea. Journal of the Chinese Chemical Society, 2008. 55(4): p. 854-857. 3. Chang, C.-T., et al., Inhibition of ROS production, autophagy or apoptosis signaling reversed the anticancer properties of Antrodia salmonea in triple-negative breast cancer (MDA-MB-231) cells. Food and Chemical Toxicology, 2017. 103: p. 1-17. 4. Hseu, Y.-C., et al., Antrodia salmonea in submerged culture exhibits antioxidant activities in vitro and protects human erythrocytes and low-density lipoproteins from oxidative modification. Food and Chemical Toxicology, 2014. 66: p. 150-157. 5. Yang, H.-L., et al., Antrodia salmonea inhibits TNF-α-induced angiogenesis and atherogenesis in human endothelial cells through the down-regulation of NF-κB and up-regulation of Nrf2 signaling pathways. Journal of ethnopharmacology, 2014. 151(1): p. 394-406. 6. Huang, G.-J., et al., Anti-inflammatory effects of ethanolic extract of Antrodia salmonea in the lipopolysaccharide-stimulated RAW246. 7 macrophages and the λ-carrageenan-induced paw edema model. Food and chemical toxicology, 2012. 50(5): p. 1485-1493. 7. 陳潔音, 香杉芝分子親緣鑑定 , 代謝物分析及其活性探索 . 中興大學森林學 系所學位論文, 2017: p. 1-76. 8. Astin, M., et al., The diagnostic value of symptoms for colorectal cancer in primary care: a systematic review. Br J Gen Pract, 2011. 61(586): p. e231-e243. 9. Fleming, M., et al., Colorectal carcinoma: pathologic aspects. Journal of gastrointestinal oncology, 2012. 3(3): p. 153. 10. Cunningham, D., et al., Colorectal cancer. The Lancet, 2010. 375(9719): p. 10301047. 11. Boleij, A., et al., Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clinical Infectious Diseases, 2011. 53(9): p. 870-878. 12. Abdulamir, A.S., R.R. Hafidh, and F.A. Bakar, The association of Streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role. Journal of Experimental & Clinical Cancer Research, 2011. 30(1): p. 11. 13. Jawad, N., N. Direkze, and S.J. Leedham, Inflammatory bowel disease and colon cancer, in Inflammation and Gastrointestinal Cancers. 2011, Springer. p. 99-115. 14. Hu, T., et al., Chronic inflammation and colorectal cancer: the role of vascular
119
endothelial growth factor. Current pharmaceutical design, 2015. 21(21): p. 29602967. 15. Bastide, N.M., F.H. Pierre, and D. Corpet, Heme iron from meat and risk of colorectal cancer: a meta-analysis and a review of the mechanisms involved. Cancer prevention research, 2011: p. canprevres. 0113.2010. 16. Sostres, C., C.J. Gargallo, and A. Lanas, Aspirin, cyclooxygenase inhibition and colorectal cancer. World journal of gastrointestinal pharmacology and therapeutics, 2014. 5(1): p. 40. 17. Govindan, R. and V.T. DeVita, DeVita, Hellman, and Rosenberg''s Cancer: Principles & Practice of Oncology Review. 2009: Lippincott Williams & Wilkins. 18. Vanneman, M. and G. Dranoff, Combining immunotherapy and targeted therapies in cancer treatment. Nature reviews cancer, 2012. 12(4): p. 237. 19. De Robertis, M., et al., The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies. Journal of carcinogenesis, 2011. 10. 20. Takayama, T., et al., Aberrant crypt foci: detection, gene abnormalities, and clinical usefulness. Clinical Gastroenterology and Hepatology, 2005. 3(7): p. S42S45. 21. Fearon, E.R., Molecular genetics of colorectal cancer. Annual Review of Pathology: Mechanisms of Disease, 2011. 6: p. 479-507. 22. Testa, U., E. Pelosi, and G. Castelli, Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells. Medical Sciences, 2018. 6(2): p. 31. 23. Armaghany, T., et al., Genetic alterations in colorectal cancer. Gastrointestinal cancer research: GCR, 2012. 5(1): p. 19. 24. Lie, D.-C., et al., Wnt signalling regulates adult hippocampal neurogenesis. Nature, 2005. 437(7063): p. 1370. 25. Morán, A., et al., Differential colorectal carcinogenesis: Molecular basis and clinical relevance. World journal of gastrointestinal oncology, 2010. 2(3): p. 151. 26. Snider, A.J., et al., Murine model for colitis-associated cancer of the colon. Mouse Models for Drug Discovery: Methods and Protocols, 2016: p. 245-254. 27. Terzić, J., et al., Inflammation and colon cancer. Gastroenterology, 2010. 138(6): p. 2101-2114. e5. 28. Jucá, M.J., et al., Comparative study of 1, 2-dimethylhydrazine and azoxymethane on the induction of colorectal cancer in rats. Journal of Coloproctology, 2014. 34(3): p. 167-173. 29. Rosenberg, D.W., C. Giardina, and T. Tanaka, Mouse models for the study of colon
120
carcinogenesis. Carcinogenesis, 2008. 30(2): p. 183-196. 30. Takahashi, M. and K. Wakabayashi, Gene mutations and altered gene expression in azoxymethane‐induced colon carcinogenesis in rodents. Cancer science, 2004. 95(6): p. 475-480. 31. Thaker, A.I., et al., Modeling colitis-associated cancer with azoxymethane (AOM) and dextran sulfate sodium (DSS). Journal of visualized experiments: JoVE, 2012(67). 32. Ahmed, D., et al., Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis, 2013. 2(9): p. e71. 33. Orrenius, S., B. Zhihotovsky, and P. Nicotera, Regulation of cell death: the calciumapoptosis link. Nature Rev Cell Biol 2003; 4: 552-65. 34. 鄧富元, et al., NFκ B 在發炎反應 , 細胞凋亡與癌症生成過程中的調控 . 中華 牙醫學雜誌 (中文版), 2006. 25(1): p. 12-24. 35. Hein, A.L., M.M. Ouellette, and Y. Yan, Radiation-induced signaling pathways that promote cancer cell survival. International journal of oncology, 2014. 45(5): p. 1813-1819. 36. Ebi, H., et al., Not just g RAS ping at flaws: Finding vulnerabilities to develop novel therapies for treating KRAS mutant cancers. Cancer science, 2014. 105(5): p. 499505. 37. Cooper, K.F., Till Death Do Us Part: The Marriage of Autophagy and Apoptosis. Oxidative medicine and cellular longevity, 2018. 2018. 38. Netea-Maier, R.T., et al., Autophagy in thyroid cancer: present knowledge and future perspectives. Frontiers in endocrinology, 2015. 6: p. 22. 39. Schmukler, E., Y. Kloog, and R. Pinkas-Kramarski, Ras and autophagy in cancer development and therapy. Oncotarget, 2014. 5(3): p. 577. 40. Coker-Gürkan, A., et al., Purvalanol induces endoplasmic reticulum stressmediated apoptosis and autophagy in a time-dependent manner in HCT116 colon cancer cells. Oncology reports, 2015. 33(6): p. 2761-2770. 41. Hyun, H.-B., et al., The flavonoid morin from Moraceae induces apoptosis by modulation of Bcl-2 family members and Fas receptor in HCT 116 cells. International journal of oncology, 2015. 46(6): p. 2670-2678. 42. Liu, Y., et al., Ginkgolic acid induces interplay between apoptosis and autophagy regulated by ROS generation in colon cancer. Biochemical and biophysical research communications, 2018. 498(1): p. 246-253. 43. Berridge, M.V., P.M. Herst, and A.S. Tan, Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnology annual review, 2005. 11: p. 127-152.
121
44. Sukhramani, P.S., et al., Biological cytotoxicity evaluation of spiro [azetidine-2, 3’indole]-2’, 4 (1’H)-dione derivatives for anti-lung and anti-breast cancer activity. Der Pharmacia Lettre, 2011. 3(5): p. 236-243. 45. Tinsley, H.N., et al., New NSAID targets and derivatives for colorectal cancer chemoprevention, in Prospects for chemoprevention of colorectal neoplasia. 2013, Springer. p. 105-120. 46. Chang, C.-T., et al., Antrodia salmonea induces G2 cell-cycle arrest in human triple-negative breast cancer (MDA-MB-231) cells and suppresses tumor growth in athymic nude mice. Journal of ethnopharmacology, 2017. 196: p. 9-19. 47. Gao, J., et al., Activation of p38-MAPK by CXCL4/CXCR3 axis contributes to p53dependent intestinal apoptosis initiated by 5-fluorouracil. Cancer biology & therapy, 2014. 15(8): p. 982-991. 48. Kim, S.-Y., et al., Role of Bcl-xL/Beclin-1 in interplay between apoptosis and autophagy in oxaliplatin and bortezomib-induced cell death. Biochemical pharmacology, 2014. 88(2): p. 178-188. 49. Hu, T., et al., Mechanisms of drug resistance in colon cancer and its therapeutic strategies. World journal of gastroenterology, 2016. 22(30): p. 6876. 50. Shant, J., et al., Akt-dependent NF-κB activation is required for bile acids to rescue colon cancer cells from stress-induced apoptosis. Experimental cell research, 2009. 315(3): p. 432-450.
|